Re-evaluating omega-3 (EPA/DHA) in cancer prevention and management

Current Opinion in Clinical Nutrition and Metabolic Care · Published 2025-11-27 · DOI 10.1097/mco.0000000000001190

Authors being retrieved — see the publisher record. https://doi.org/10.1097/mco.0000000000001190

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Effect of Ultra Processed Foods on Cancer Risk and Strategies for Risk Mitigation · Current Nutrition Reports · 2026 · Cites or is cited by this article
• Lipids as biological response modifiers: from epidemiology to molecular mechanisms · Current Opinion in Clinical Nutrition and Metabolic Care · 2026 · Same journal
• Pediatric nutrition: from premature infants to adolescents · Current Opinion in Clinical Nutrition and Metabolic Care · 2026 · Same journal
• Growth differentiation factor 15 as a biomarker of frailty: evidence from recent studies · Current Opinion in Clinical Nutrition and Metabolic Care · 2026 · Same journal
• Perioperative drug pharmacokinetics in patients with obesity · Current Opinion in Clinical Nutrition and Metabolic Care · 2026 · Same journal
• Dietary leucine intake and sarcopenia: from isolated supplementation to combined strategies · Current Opinion in Clinical Nutrition and Metabolic Care · 2025 · Same journal
• A viewpoint review of recent policy changes and public health initiatives to combat obesity · Current Opinion in Clinical Nutrition and Metabolic Care · 2026 · Same journal
• Plasma amino acid signatures and cardiometabolic risk: Cause or consequence? · Current Opinion in Clinical Nutrition and Metabolic Care · 2025 · Same journal
• Measuring nutrient content in human milk: are we there yet? · Current Opinion in Clinical Nutrition and Metabolic Care · 2026 · Same journal
• Anabolic resistance in cancer cachexia: a role for sex and chemotherapy · Current Opinion in Clinical Nutrition and Metabolic Care · 2026 · Same journal